Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors
Author:
Affiliation:
1. Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
2. Department of Oncology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
Publisher
Informa UK Limited
Subject
Oncology,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2019.1659094
Reference56 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000
3. New Strategies in Advanced Cervical Cancer: From Angiogenesis Blockade to Immunotherapy
4. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis
5. Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy
Cited by 115 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis;Computational and Structural Biotechnology Journal;2024-12
2. Granulocytes and mast cells in AllergoOncology—Bridging allergy to cancer: An EAACI position paper;Allergy;2024-07-22
3. Comprehensive pan‐cancer analysis of mitochondrial outer membrane permeabilisation activity reveals positive immunomodulation and assists in identifying potential therapeutic targets for immunotherapy resistance;Clinical and Translational Medicine;2024-06
4. Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer;Scientific Reports;2024-05-17
5. Immune-related LncRNAs scores predicts chemotherapeutic responses and prognosis in cervical cancer patients;Discover Oncology;2024-04-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3